These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis. Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716 [TBL] [Abstract][Full Text] [Related]
27. Timing of Anticoagulation in Patients with Cerebral Venous Thrombosis Requiring Decompressive Surgery: Systematic Review of the Literature and Case Series. Salottolo K; Bartt R; Frei DF; Bellon RJ; Atchie B; McCarthy K; Bar-Or D World Neurosurg; 2020 May; 137():408-414. PubMed ID: 32105874 [TBL] [Abstract][Full Text] [Related]
28. Treatment Failure of Cerebral Venous Thrombosis With Rivaroxaban: A Case Report and Narrative Review. Mohamed M; Musa M; Fadul A; Abdallah I; Najim M; Saeed A Cureus; 2022 Apr; 14(4):e23778. PubMed ID: 35382062 [TBL] [Abstract][Full Text] [Related]
29. Cerebral Venous Thrombosis Associated with Intracranial Hemorrhage and Timing of Anticoagulation after Hemicraniectomy. Pizzi MA; Alejos DA; Siegel JL; Kim BY; Miller DA; Freeman WD J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2312-6. PubMed ID: 27321968 [TBL] [Abstract][Full Text] [Related]
30. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Yaghi S; Shu L; Bakradze E; Salehi Omran S; Giles JA; Amar JY; Henninger N; Elnazeir M; Liberman AL; Moncrieffe K; Lu J; Sharma R; Cheng Y; Zubair AS; Simpkins AN; Li GT; Kung JC; Perez D; Heldner M; Scutelnic A; Seiffge D; Siepen B; Rothstein A; Khazaal O; Do D; Kasab SA; Rahman LA; Mistry EA; Kerrigan D; Lafever H; Nguyen TN; Klein P; Aparicio H; Frontera J; Kuohn L; Agarwal S; Stretz C; Kala N; El Jamal S; Chang A; Cutting S; Xiao H; de Havenon A; Muddasani V; Wu T; Wilson D; Nouh A; Asad SD; Qureshi A; Moore J; Khatri P; Aziz Y; Casteigne B; Khan M; Cheng Y; Mac Grory B; Weiss M; Ryan D; Vedovati MC; Paciaroni M; Siegler JE; Kamen S; Yu S; Leon Guerrero CR; Atallah E; De Marchis GM; Brehm A; Dittrich T; Psychogios M; Alvarado-Dyer R; Kass-Hout T; Prabhakaran S; Honda T; Liebeskind DS; Furie K Stroke; 2022 Mar; 53(3):728-738. PubMed ID: 35143325 [TBL] [Abstract][Full Text] [Related]
31. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107 [TBL] [Abstract][Full Text] [Related]
32. Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis. Ferro JM; Dentali F; Coutinho JM; Kobayashi A; Caria J; Desch M; Fraessdorf M; Huisman H; Diener HC Int J Stroke; 2018 Oct; 13(7):766-770. PubMed ID: 29775170 [TBL] [Abstract][Full Text] [Related]
33. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. Ferro JM; Coutinho JM; Dentali F; Kobayashi A; Alasheev A; Canhão P; Karpov D; Nagel S; Posthuma L; Roriz JM; Caria J; Frässdorf M; Huisman H; Reilly P; Diener HC; JAMA Neurol; 2019 Dec; 76(12):1457-1465. PubMed ID: 31479105 [TBL] [Abstract][Full Text] [Related]
34. Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 Vaccination. Scutelnic A; Krzywicka K; Mbroh J; van de Munckhof A; van Kammen MS; de Sousa DA; Lindgren E; Jood K; Günther A; Hiltunen S; Putaala J; Tiede A; Maier F; Kern R; Bartsch T; Althaus K; Ciccone A; Wiedmann M; Skjelland M; Medina A; Cuadrado-Godia E; Cox T; Aujayeb A; Raposo N; Garambois K; Payen JF; Vuillier F; Franchineau G; Timsit S; Bougon D; Dubois MC; Tawa A; Tracol C; De Maistre E; Bonneville F; Vayne C; Mengel A; Michalski D; Pelz J; Wittstock M; Bode F; Zimmermann J; Schouten J; Buture A; Murphy S; Palma V; Negro A; Gutschalk A; Nagel S; Schoenenberger S; Frisullo G; Zanferrari C; Grillo F; Giammello F; Martin MM; Cervera A; Burrow J; Esperon CG; Chew BLA; Kleinig TJ; Soriano C; Zimatore DS; Petruzzellis M; Elkady A; Miranda MS; Fernandes J; Vogel ÅH; Johansson E; Philip AP; Coutts SB; Bal S; Buck B; Legault C; Blacquiere D; Katzberg HD; Field TS; Dizonno V; Gattringer T; Jacobi C; Devroye A; Lemmens R; Kristoffersen ES; di Poggio MB; Ghiasian M; Karapanayiotides T; Chatterton S; Wronski M; Ng K; Kahnis R; Geeraerts T; Reiner P; Cordonnier C; Middeldorp S; Levi M; van Gorp ECM; van de Beek D; Brodard J; Kremer Hovinga JA; Kruip MJHA; Tatlisumak T; Ferro JM; Coutinho JM; Arnold M; Poli S; Heldner MR Ann Neurol; 2022 Oct; 92(4):562-573. PubMed ID: 35689346 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany. Schulz JB; Berlit P; Diener HC; Gerloff C; Greinacher A; Klein C; Petzold GC; Piccininni M; Poli S; Röhrig R; Steinmetz H; Thiele T; Kurth T; Ann Neurol; 2021 Oct; 90(4):627-639. PubMed ID: 34288044 [TBL] [Abstract][Full Text] [Related]
36. Rivaroxaban for the treatment of cerebral venous thrombosis: a single-center experience. Bajko Z; Maier S; Motataianu A; Filep RC; Stoian A; Andone S; Balasa R Acta Neurol Belg; 2022 Feb; 122(1):105-111. PubMed ID: 33733345 [TBL] [Abstract][Full Text] [Related]